OZT: Balloon Aortic Valvuloplasty

Product code OZT, “Balloon Aortic Valvuloplasty” in FDA's classification database, is a Class II device type under 21 CFR 870.1255 (balloon aortic valvuloplasty catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 22 clearances under OZT, 22 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
OZT
Regulation
21 CFR 870.1255
Class
II
Panel
Cardiovascular
Clearances
22
Most recent
May 6, 2026
Median review, last 2 years
154 days
Third-party review
Not eligible
Implant
No

What it covers

A balloon aortic valvuloplasty catheter is indicated for balloon valvuloplasty of the aortic valve.

FDA’s definition of product code OZT, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K253855KardiaPSI Balloon CatheterIntervention Tech, Inc. ; dba CorventionMay 6, 2026Traditional
K260437Valvuloplasty Balloon Catheter (ValvuloPro)Dongguan TT Medical, Inc.Mar 20, 2026Special
K241562OutFlo Aortic Valve Dilatation Balloon CatheterDisa MedinotecMar 11, 2025Traditional
K240967ValvuloPro Valvuloplasty Balloon CatheterDongguan TT Medical, Inc.Jul 31, 2024Special
K231814ValvuloPro Valvuloplasty Balloon CatheterDongguan TT Medical, Inc.Oct 12, 2023Traditional
K220881INOUE BALLOON AToray Industries, Inc.Dec 18, 2022Traditional
K172932True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc.Dec 13, 2017Traditional
K152613True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc.Jan 19, 2016Traditional
K152150V8 Balloon Aortic Valvuloplasty CatheterIntervalve, Inc.Dec 18, 2015Traditional
K150667True Dilatation Balloon Valvuloplasty CatheterC.R. Bard, Inc.Jun 17, 2015Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 22 with a free account)

Clearances by year

22 OZT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)296
20251284
20241113
20231113
20221268
2017178
20161127
20154115
2014479
2013380
20123184

Who submits

11 applicants cleared a OZT device since 2011. 77% of the clearances went to applicants in United States, then China (14%), Japan (5%) and South Africa (5%). By type: Traditional 73%, Special 23% and Post-NSE 5%.

ApplicantClearances since 2011
C.R. Bard, Inc.5
Intervalve, Inc.5
Dongguan TT Medical, Inc.3
NuMED, Inc.2
Bard Peripheral Vascular, Inc.1
Disa Medinotec1
Edwards Lifesciences1
Edwards Lifesciences, LLC1

How FDA classifies it

Class II (special controls). The special controls for this device are:

(1) The device must be demonstrated to be biocompatible.

(2) Sterility and shelf life testing must demonstrate the sterility of patient-contacting components and the shelf life of these components.

(3) Non-clinical performance evaluation must demonstrate that the device performs as intended under anticipated conditions of use, including device delivery, inflation, deflation, and removal.

(4) In vivo evaluation of the device must demonstrate device performance, including the ability of the device to treat aortic stenosis.

(5) Labeling must include a detailed summary of the device-related and procedure-related complications pertinent to the use of the device.

From 21 CFR 870.1255. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 870.1255 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent OZT clearances declared.

Ask about OZT

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about OZT

What is FDA product code OZT?

Product code OZT, “Balloon Aortic Valvuloplasty” in FDA's classification database, is a Class II device type under 21 CFR 870.1255 (balloon aortic valvuloplasty catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 22 clearances under OZT, 22 of them since 2011.

How many 510(k) clearances are there under OZT?

FDA’s 510(k) database listed 22 clearances under OZT as of Oct 29, 2026, 22 of them decided since 2011; the most recent decision was May 6, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a OZT 510(k)?

For the 3 OZT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 154 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most OZT clearances?

Since 2011: C.R. Bard, Inc. (5), Intervalve, Inc. (5), Dongguan TT Medical, Inc. (3), NuMED, Inc. (2) and Bard Peripheral Vascular, Inc. (1). 11 applicants have cleared a OZT device in that time.

Sources

  1. FDA product classification: OZT · Product Classification database
  2. 21 CFR 870.1255: Balloon aortic valvuloplasty catheter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for OZT · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow OZTGet an email when FDA clears, recalls or publishes guidance for OZT devices.

Know what FDA already cleared.